Shoulder Innovations (SI) Net Income towards Common Stockholders (2024 - 2026)
Shoulder Innovations' (SI) quarterly Net Income towards Common Stockholders came in at -$10.2 million in Q2 2026, up 47.11% on a YoY basis from -$6.9 million in Q2 2025, and down 21.17% quarter-over-quarter from -$8.4 million in Q1 2026.
Analysis
Shoulder Innovations (SI) Net Income towards Common Stockholders (2024 - 2026) Analysis & Trends
Shoulder Innovations (SI) has reported Net Income towards Common Stockholders for 3 consecutive years, with -$10.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 47.11% year-over-year to -$10.2 million; the trailing twelve-month figure through Jun 2026 stood at -$35.0 million (down 10.5% YoY), and the FY2025 full-year result was -$40.4 million, down 158.4% from the prior year.
- Net Income towards Common Stockholders fell to -$10.2 million in Q2 2026 per SI's latest filing, from -$8.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$3.8 million in Q4 2024 and bottomed at -$19.2 million in Q2 2025.
- Historically, Net Income towards Common Stockholders has averaged -$7.9 million across 3 years, with a median of -$7.8 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Net Income towards Common Stockholders tumbled 360.12% in 2025, then soared 47.11% in 2026.
- Over 3 years, Net Income towards Common Stockholders stood at -$3.8 million in 2024, then tumbled by 104.96% to -$7.8 million in 2025, then slumped by 30.64% to -$10.2 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$10.2 million, -$8.4 million, and -$7.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.61 Bn | 179.00 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 126.43 Bn | 121.22 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 119.26 Bn | 110.45 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 106.19 Bn | 102.71 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 67.54 Bn | 67.00 Bn | 3.85 Bn | 907.00 Mn |
| 6 | Edwards Lifesciences | 50.12 Bn | 45.87 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 34.19 Bn | 32.73 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.88 Bn | 29.94 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.21 Bn | 20.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Shoulder Innovations | 414.20 Mn | 315.20 Mn | 13.44 Mn | -10.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.15 Mn |
| Mar 31, 2026 | -8.38 Mn |
| Dec 31, 2025 | -7.77 Mn |
| Sep 30, 2025 | -8.73 Mn |
| Jun 30, 2025 | -19.20 Mn |
| Mar 31, 2025 | -4.66 Mn |
| Dec 31, 2024 | -3.79 Mn |
| Sep 30, 2024 | -4.06 Mn |
| Jun 30, 2024 | -4.17 Mn |